T1	Outcomes 37 78	postoperative pain and local inflammation
T2	Outcomes 199 207	efficacy
T3	Outcomes 666 673	points.
T4	Outcomes 674 682	Efficacy
T5	Outcomes 696 876	by total amount of morphine consumed, pain intensity, range of motion (ROM), the concentration change of PGE-2 and IL-6 of joint fluid, and postoperative nausea and vomiting (PONV)
T6	Outcomes 941 954	less morphine
T7	Outcomes 980 996	less pain scores
T8	Outcomes 1025 1033	more ROM
T9	Outcomes 1098 1114	postoperatively.
T10	Outcomes 1115 1159	The concentration of PGE-2 and IL-6 of joint
T11	Outcomes 1258 1274	postoperatively.
T12	Outcomes 1275 1296	The overall incidence
T13	Outcomes 1499 1542	improved postoperative analgesic management
T14	Outcomes 1577 1607	requirement, lower pain scores
T15	Outcomes 1621 1674	significantly lowered local inflammation factors PGE2
